C <scp>entre‐based</scp> comparison of double versus single prevention strategy on transfusion‐ <scp>transmitted cytomegalovirus</scp> in <scp>at‐risk</scp> haemopoietic stem cell transplant patients and a state survey on cytomegalovirus <scp>‐seronegative</scp> ordering practises-Reference-Cited by-同舟云学术

C entre‐based comparison of double versus single prevention strategy on transfusion‐ transmitted cytomegalovirus in at‐risk haemopoietic stem cell transplant patients and a state survey on cytomegalovirus ‐seronegative ordering practises

Published:2022-09-02 Issue: Volume: Page:
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Zantomio Daniela¹²^ORCID,Bayly Emma¹³,Wong Kimberly¹⁴,Spencer Andrew⁵,Ritchie David⁶,Morgan Susan⁴,Kelsey Giles³⁴,Dennington Peta M.¹

Affiliation:

1. Pathology Services Australian Red Cross Lifeblood Australia

2. Department of Haematology Austin Health Melbourne Victoria Australia

3. Laboratory Haematology Royal Melbourne Hospital Melbourne Victoria Australia

4. Laboratory Haematology Alfred Hospital Melbourne Victoria Australia

5. Department of Haematology and Bone Marrow Transplant Alfred Health Melbourne Victoria Australia

6. Clinical Haematology Peter MacCallum Cancer Centre and Royal Melbourne Hospital Melbourne Victoria Australia

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.15751

Reference17 articles.

1. Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction;Ljungman P;Br J Haematol,2004

2. Where do we stand after decades of studying human cytomegalovirus?;Gugliesi F;Microorganisms,2020

3. A comparison of filtered leukocyte‐reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion‐associated CMV infection after marrow transplant;Bowden RA;Blood,1995

4. European committee on blood transfusion.Guide to the preparation use and quality assurance of blood components.Recommendation no R (95) 15. 20th edn. Strabourge France: European Directorate for the Quality of Medicines & HealthCare of the Council of Europe2020195‐245.

5. Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (commentary, p. 3026);Atreya C;Transfusion,2019